Interventional Oncology Devices Market Size, Share, Industry, Forecast and outlook (2024-2030)

The global Interventional Oncology Devices Market is expected to grow at a high CAGR during the forecast period of 2024-2030, driven by factors like rising public-private funding, technological advancements, and increasing patient preference for minimally invasive procedures.

Major players are Medtronic, Boston Scientific, BD, Terumo, Merit Medical, AngioDynamics, J&J, Teleflex, Cook Medical, and HealthTronics.

North America currently holds the largest market share due to the high incidence of liver cancer, the presence of key players, and ongoing product launches. However, the Asia Pacific region is projected to be the fastest-growing market due to the rising burden of cancer and increasing healthcare spending.

Interventional oncology procedures encompass minimally invasive techniques for diagnosis and treatment using image guidance. Some common procedures include thermal tumor ablation, radiofrequency ablation, and transarterial chemoembolization.